Bilimsel Makale Arama | NeuralCipher AI

Açık erişim

The Efficacy and Safety of Monoclonal Antibodies That Target Alpha-Synuclein in Parkinson's Disease: A Systematic Review.

Coles D, Kalyana A, Khalil S, Chauhan D, Rupasinghe T, Costello C, Batla A, Young T.

Parkinsons Dis · 2026-07-22

DOI: 10.1155/padi/8540084PMID: 42495570

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Correction: GATD3A-mediated monocyte homeostasis and compartmentalized erythrocyte alpha-synuclein discriminate early Parkinson's disease from MSA-P.

Jiang Y, Xu C, Jin J, Liu X, Cai H, Zhang W, Zheng X, Wu J, Wang Z, Piao Y, Feng T.

Front Immunol · 2026-07-20

DOI: 10.3389/fimmu.2026.1934828PMID: 42549319

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

The conundrum of alpha-synuclein antibody failures in Parkinson's disease: a narrative review of mechanisms and alternative metabolic hypotheses.

Bougea A.

Ther Adv Neurol Disord · 2026-07-14

DOI: 10.1177/17562864261465665PMID: 42459575

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

GATD3A-mediated monocyte homeostasis and compartmentalized erythrocyte alpha-synuclein discriminate early Parkinson's disease from MSA-P.

Jiang Y, Xu C, Jin J, Liu X, Cai H, Zhang W, Zheng X, Wu J, Wang Z, Piao Y, Feng T.

Front Immunol · 2026-07-09

DOI: 10.3389/fimmu.2026.1818028PMID: 42549349

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Roles of astrocytic Connexin 43 gap junctional deficit in alpha-synucleinopathy and inflammation relevant to Parkinson's.

Hastings N, Rahman S, Kuan WL, Alfaidi M, Fox S, Erkamp NA, Andrzejewska E, Whitehead M, Zakirov A, Unwin RD, Baranes K, Schmidt R, Oliinyk A, Aref D, Brotchie J, Knowles TPJ, Malliaras GG, Kotter MRN.

Exp Neurol · 2026-06-26

DOI: 10.1016/j.expneurol.2026.115897PMID: 42362037

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease.

Adler CH, Janarthanam C, Serrano GE, Anantharam V, Beach TG, Shill H, Driver-Dunckley E, Mehta SH, Atri A, Belden CM, Kanthasamay A.

Neurology · 2026-06-25

DOI: 10.1212/wnl.0000000000218121PMID: 42348807

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Deep brain stimulation in alpha-synuclein models of Parkinson's disease: Bridging the translational gap.

Kondrataviciute L, Weber H, Kapadia M, Aguirre-Padilla DH, Fauser M, Valiante TA, Hutchison WD, Milosevic L, Storch A, Kalia LV, Kalia SK.

J Parkinsons Dis · 2026-06-16

DOI: 10.1177/1877718x261459876PMID: 42299658

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

Biomarkers stewardship in parkinsonism: integrating alpha-synuclein seed amplification assays and neurofilament light chain into diagnostic pathways and patient communication.

Leclercq V.

J Neurol · 2026-06-15

DOI: 10.1007/s00415-026-13933-8PMID: 42295486

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

Phytochemical engineered quantum dots as potential therapy to counter alpha synuclein aggregation in Parkinson's disease.

Shashwat P, Kirthi AV, Selvaraj M, Karnwal A, Dutta J.

Neurochem Int · 2026-06-02

DOI: 10.1016/j.neuint.2026.106194PMID: 42235756

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

GRP78 associates with alpha-synuclein in vulnerable neurons of the Parkinson's disease brain.

Hrabos D, Mrowiecova A, Cicmancova J, Ehrmann J.

Acta Neuropathol · 2026-05-30

DOI: 10.1007/s00401-026-03034-1PMID: 42217054

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kaynak kaydı

A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson's Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response.

Volc D, Thun-Hohenstein C, Schmidhuber S, Mandler M, Schneeberger A.

Vaccines (Basel) · 2026-05-23

DOI: 10.3390/vaccines14060466PMID: 42347588

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Açık erişim

p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease.

Hou K, Chen J, Xie Y, Liu T, Li J, Meng C, Niu D, Xian M, Li J, Zhu C, Li H, Wei J.

J Biol Chem · 2026-05-23

DOI: 10.1016/j.jbc.2026.113184PMID: 42178109

Europe PMC üzerinden doğrulanabilir bibliyografik kayıt.

Makale detayına git Kaynağa git ↗

Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.

715 makale bulundu

The Efficacy and Safety of Monoclonal Antibodies That Target Alpha-Synuclein in Parkinson's Disease: A Systematic Review.

Correction: GATD3A-mediated monocyte homeostasis and compartmentalized erythrocyte alpha-synuclein discriminate early Parkinson's disease from MSA-P.

The conundrum of alpha-synuclein antibody failures in Parkinson's disease: a narrative review of mechanisms and alternative metabolic hypotheses.

GATD3A-mediated monocyte homeostasis and compartmentalized erythrocyte alpha-synuclein discriminate early Parkinson's disease from MSA-P.

Roles of astrocytic Connexin 43 gap junctional deficit in alpha-synucleinopathy and inflammation relevant to Parkinson's.

Alpha-Synuclein Seed Amplification Assay in CSF, Skin, and Submandibular Gland From Incidental Lewy Body Disease and Parkinson Disease.

Deep brain stimulation in alpha-synuclein models of Parkinson's disease: Bridging the translational gap.

Biomarkers stewardship in parkinsonism: integrating alpha-synuclein seed amplification assays and neurofilament light chain into diagnostic pathways and patient communication.

Phytochemical engineered quantum dots as potential therapy to counter alpha synuclein aggregation in Parkinson's disease.

GRP78 associates with alpha-synuclein in vulnerable neurons of the Parkinson's disease brain.

A Case Report of a Novel Alpha-Synuclein Vaccine (TRB-001) in a Parkinson's Patient: Safe Administration and Induction of a High-Titer, High-Avidity Functional Antibody Response.

p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease.

Filtreler